ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Bevacizumab in Treating Patients With Recurrent Sex Cord-Stromal Tumors of the Ovary

ClinicalTrials.gov ID: NCT00748657

Public ClinicalTrials.gov record NCT00748657. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 1:31 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II Trial of NCI-Supplied Agent: Bevacizumab (rhuMAB VEGF) (NSC# 704865) for Recurrent Sex Cord-Stromal Tumors of the Ovary

Study identification

NCT ID
NCT00748657
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
National Cancer Institute (NCI)
NIH
Enrollment
36 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 21, 2008
Primary completion
Jan 30, 2013
Completion
Jan 30, 2013
Last update posted
Jul 22, 2019

2008 – 2013

United States locations

U.S. sites
36
U.S. states
16
U.S. cities
27
Facility City State ZIP Site status
Los Angeles County-USC Medical Center Los Angeles California 90033
USC / Norris Comprehensive Cancer Center Los Angeles California 90033
University of Colorado Hospital Aurora Colorado 80045
Hartford Hospital Hartford Connecticut 06102
The Hospital of Central Connecticut New Britain Connecticut 06050
Northeast Georgia Medical Center-Gainesville Gainesville Georgia 30501
Northwestern University Chicago Illinois 60611
University of Chicago Comprehensive Cancer Center Chicago Illinois 60637
Hinsdale Hematology Oncology Associates Incorporated Hinsdale Illinois 60521
Sudarshan K Sharma MD Limted-Gynecologic Oncology Hinsdale Illinois 60521
University of Iowa/Holden Comprehensive Cancer Center Iowa City Iowa 52242
Massachusetts General Hospital Cancer Center Boston Massachusetts 02114
University of Massachusetts Memorial Health Care Worcester Massachusetts 01605
University of Massachusetts Medical School Worcester Massachusetts 01655
University of Minnesota/Masonic Cancer Center Minneapolis Minnesota 55455
University of Mississippi Medical Center Jackson Mississippi 39216
Nebraska Methodist Hospital Omaha Nebraska 68114
Memorial Sloan-Kettering Cancer Center New York New York 10065
Carolinas Medical Center/Levine Cancer Institute Charlotte North Carolina 28203
Duke University Medical Center Durham North Carolina 27710
Case Western Reserve University Cleveland Ohio 44106
MetroHealth Medical Center Cleveland Ohio 44109
Cleveland Clinic Cancer Center/Fairview Hospital Cleveland Ohio 44111
Cleveland Clinic Foundation Cleveland Ohio 44195
Ohio State University Comprehensive Cancer Center Columbus Ohio 43210
Riverside Methodist Hospital Columbus Ohio 43214
Miami Valley Hospital Dayton Ohio 45409
Hillcrest Hospital Cancer Center Mayfield Heights Ohio 44124
Lake University Ireland Cancer Center Mentor Ohio 44060
University of Oklahoma Health Sciences Center Oklahoma City Oklahoma 73104
Oklahoma Cancer Specialists and Research Institute-Tulsa Tulsa Oklahoma 74146
Abington Memorial Hospital Abington Pennsylvania 19001
Fox Chase Cancer Center Philadelphia Pennsylvania 19111
Parkland Memorial Hospital Dallas Texas 75235
UT Southwestern/Simmons Cancer Center-Dallas Dallas Texas 75390
M D Anderson Cancer Center Houston Texas 77030

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00748657, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 22, 2019 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00748657 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →